1Sakata Y,Yamamoto K,Mano T,et al.Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats:its inhibition as a primary effect of angiotensin-converting enzyme inhibitor[J].Circulation,2004,109(17):2143.
4Yamazaki T,Lee JD,Shimizu H,et al.Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure[J].Eur J Heart Fail,2004,6(1):41.
5Francis GS,Cohn JN,Johnson G,et al.Plasma noradrrenaline,plasma rennin activity and congestive heart failure:relation to survival and the effects of therapy in V-HeFT II[J].Circulation,1993,87(suppl VI):40.
10Usui M,Cohen ML.Effects of oxidized low-density lipoprotein on vascular constraction and relaxation:clinical and pharmacological implication in atherosclerosis[J].Life Sci,1998,62(26):2425.
3[1]Cleutjens J P M. The role of matrix metalloproteinases in heart failure. Cardivas Res, 1996,32:816-821.
4[2]Cleutjens J P M, Kandala J C, Guarda E, et al. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol, 1995, 27: 1281-1292.
5[3]Spinale F G, Coker M L, Thomas C V, et al. Time-dependent changes in matrix metalloproteinase activity during the progression of congestive heart failure. Relative to ventricular and myocyte function. Cir Res, 1998,82:482-495.
6[4]Thomas C V, Coker M L, Zellner J L, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation, 1998,97:1708-1715.
7[5]Huang Y F, Kawaguchi O, Zeng B, et al. A stable ovine congestive heart failure model. A suitable substrate for left ventricular assist device assessment. ASAIO J, 1997,43:M408-413.
8[6]Mann D L, Spinalae F G. Activation of matrix metalloproteinases in the failing human heart. Breaking the tie that bands. Circulation, 1998,98:1699-1702.
9[7]Coker M L, Thomas C V, Clair M J, et al. Myocardial matrix metallotroteinases activity and aboundance with congestive heart failure. Am J Pathol, 1998,274(5 Pt 2): H1516-1523.
10[8]Gilbert S J, Wotton P R, Tarlton J F, et al. Increased expression of promatrix metalloproteinase-9 and neutrophil elastase in canine dilated cardiomyopathy. Cardiovasc Res, 1997,34:377-383.
